Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-03-18 00:27 | 2021-03-16 | ADI | Analog Devices, Inc. | GLIMCHER LAURIE H M.D. | Director | Semiconductors & Related Devices | SALE | $154.07 | 460 | $70,874 | 600 | -43.4% |
| 2019-11-04 16:30 | 2019-11-01 | WAT | WATERS CORP /DE/ | GLIMCHER LAURIE H M.D. | Director | Laboratory Analytical Instruments | SALE | $214.64 | 2,200 | $472,208 | 3,600 | -37.9% |
| 2019-02-27 16:45 | 2019-02-26 | WAT | WATERS CORP /DE/ | GLIMCHER LAURIE H M.D. | Director | Laboratory Analytical Instruments | SALE | $238.69 | 1,485 | $354,455 | 5,800 | -20.4% |
| 2017-05-22 16:39 | 2017-05-19 | WAT | WATERS CORP /DE/ | GLIMCHER LAURIE H M.D. | Director | Laboratory Analytical Instruments | OPT+S | $175.78 | 4,800 | $843,720 | 6,849 | -41.2% |
| 2016-08-01 18:42 | 2016-07-28 | WAT | WATERS CORP /DE/ | GLIMCHER LAURIE H M.D. | Director | Laboratory Analytical Instruments | OPT+S | $156.38 | 4,000 | $625,528 | 8,961 | -30.9% |
| 2015-05-04 16:51 | 2015-05-01 | WAT | WATERS CORP /DE/ | GLIMCHER LAURIE H M.D. | Director | Laboratory Analytical Instruments | OPT+S | $126.40 | 4,000 | $505,600 | 5,200 | -43.5% |
| 2014-07-30 22:41 | 2014-07-29 | WAT | WATERS CORP /DE/ | GLIMCHER LAURIE H M.D. | Director | Laboratory Analytical Instruments | SALE | $105.65 | 5,500 | $581,075 | 4,000 | -57.9% |
| 2014-02-18 16:20 | 2014-02-13 | WAT | WATERS CORP /DE/ | GLIMCHER LAURIE H M.D. | Director | Laboratory Analytical Instruments | OPT+S | $112.00 | 2,900 | $324,800 | 9,500 | -23.4% |
| 2013-11-13 00:30 | 2013-11-08 | WAT | WATERS CORP /DE/ | GLIMCHER LAURIE H M.D. | Director | Laboratory Analytical Instruments | OPT+S | $100.00 | 2,400 | $240,000 | 8,000 | -23.1% |
| 2013-01-31 00:16 | 2013-01-30 | BMY | BRISTOL MYERS SQUIBB CO | GLIMCHER LAURIE H M.D. | Director | Pharmaceutical Preparations | OPT+S | $36.40 | 11,000 | $400,400 | 0 | -100.0% |
| 2013-01-28 18:33 | 2013-01-25 | WAT | WATERS CORP /DE/ | GLIMCHER LAURIE H M.D. | Director | Laboratory Analytical Instruments | OPT+S | $91.87 | 6,800 | $624,712 | 8,000 | -45.9% |
| 2012-11-07 18:48 | 2012-11-06 | WAT | WATERS CORP /DE/ | GLIMCHER LAURIE H M.D. | Director | Laboratory Analytical Instruments | OPT+S | $84.74 | 1,000 | $84,740 | 6,500 | -13.3% |
| 2012-05-10 19:20 | 2012-05-09 | WAT | WATERS CORP /DE/ | GLIMCHER LAURIE H M.D. | Director | Laboratory Analytical Instruments | OPT+S | $83.78 | 2,000 | $167,560 | 6,500 | -23.5% |
| 2012-03-20 23:45 | 2012-03-16 | BMY | BRISTOL MYERS SQUIBB CO | GLIMCHER LAURIE H M.D. | Director | Pharmaceutical Preparations | OPT+S | $33.18 | 3,500 | $116,130 | 0 | -100.0% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.